bkrisrecast2025

Financial Supplement - Baker Hughes (unaudited) Exhibit 99.1 Copyright 2025 Baker Hughes Company. All rights reserved. Note: certain columns and rows may not add up due to the use of rounded numbers. Income Statement Recast ($ in millions) Reported Recasted Reported Recasted Reported Recasted Revenue: FY 2022 R&D* Other Charges NonOp* FY 2022 FY 2023 R&D* Other Charges NonOp* FY 2023 FY 2024 R&D* Other Charges NonOp* FY 2024 Sales of goods $ 12,236 $ 12,236 $ 15,617 $ 15,617 $ 17,810 $ 17,810 Sales of services 8,920 8,920 9,889 9,889 10,019 10,019 Total Revenue 21,156 — — — 21,156 25,506 — — — 25,506 27,829 — — — 27,829 Costs and expenses: Cost of goods sold (1) 10,445 (433) 10,012 13,309 (508) 12,801 14,792 (501) 14,291 Cost of services sold (1) 6,311 (119) 6,192 6,946 (143) 6,803 7,197 (142) 7,055 Selling, general and administrative 2,510 2,510 2,611 2,611 2,458 2,458 Research and development costs (1) — 552 552 — 651 651 — 643 643 Restructuring (2) 705 (509) 196 323 (10) 313 301 (41) 260 Other (income) expense, net (2)(3) — 509 911 1,420 — 10 (554) (544) — 41 (382) (341) Other non-operating (income) loss (3) 911 (911) — (554) 554 — (382) 382 — Interest expense, net 252 252 216 216 198 198 Income before income taxes 22 — — — 22 2,655 — — — 2,655 3,265 — — — 3,265 Provision for income taxes (600) (600) (685) (685) (257) (257) Net income (loss) (578) — — — (578) 1,970 — — — 1,970 3,008 — — — 3,008 Less: Net income attributable to noncontrolling interests 23 23 27 27 29 29 Net income (loss) attributable to Baker Hughes Company $ (601) $ — $ — $ — $ (601) $ 1,943 $ — $ — $ — $ 1,943 $ 2,979 $ — $ — $ — $ 2,979 Table 1. Reconciliation of Consolidated Statements of Income (Loss) - Reported to Recasted View (1) Cost of sales excludes "Research and development costs," which are now separately stated on the Consolidated statements of income (loss) (2) The caption previously named "Restructuring, Impairment & Other" has been renamed to "Restructuring" with all non-restructuring costs reclassified to "Other (income) expense, net" (3) Costs previously reported in "Other non-operating (income) loss" will now be classified in "Other (income) expense, net" * Defined as: R&D: "Research and development costs" and NonOp: "Other non-operating (income) loss"

Financial Supplement - Baker Hughes (unaudited) Exhibit 99.1 Copyright 2025 Baker Hughes Company. All rights reserved. Income Statement Recast Revenue: 1Q 2022 2Q 2022 3Q 2022 4Q 2022 FY 2022 1Q 2023 2Q 2023 3Q 2023 4Q 2023 FY 2023 1Q 2024 2Q 2024 3Q 2024 4Q 2024 FY 2024 Sales of goods $ 2,809 $ 2,817 $ 3,084 $ 3,526 $ 12,236 $ 3,484 $ 3,793 $ 4,044 $ 4,297 $ 15,617 $ 3,999 $ 4,552 $ 4,413 $ 4,847 $ 17,810 Sales of services 2,026 2,230 2,285 2,379 8,920 2,232 2,522 2,597 2,538 9,889 2,419 2,587 2,495 2,517 10,019 Total Revenue 4,835 5,047 5,369 5,905 21,156 5,716 6,315 6,641 6,835 25,506 6,418 7,139 6,908 7,364 27,829 Costs and expenses: Cost of goods sold (1) 2,271 2,388 2,535 2,818 10,012 2,860 3,136 3,343 3,463 12,801 3,276 3,657 3,459 3,899 14,291 Cost of services sold (1) 1,475 1,552 1,578 1,586 6,192 1,548 1,716 1,790 1,748 6,803 1,700 1,834 1,749 1,771 7,055 Selling, general and administrative 621 624 620 645 2,510 655 695 627 634 2,611 618 643 612 585 2,458 Research and development costs (1) 119 137 132 164 552 159 152 165 175 651 164 158 158 163 643 Restructuring (2) 4 25 146 21 196 56 96 5 155 313 — 2 — 258 260 Other (income) expense, net (2)(3) 94 916 149 262 1,420 (386) (152) (97) 93 (544) (22) (26) (134) (158) (341) Interest expense, net 64 60 65 64 252 64 58 49 45 216 41 47 55 54 198 Income (loss) before income taxes 187 (655) 144 345 22 760 614 759 522 2,655 641 824 1,009 792 3,265 Benefit (provision) for income taxes (107) (182) (153) (157) (600) (179) (200) (235) (72) (685) (178) (243) (235) 398 (257) Net income (loss) 80 (837) (9) 188 (578) 581 414 524 450 1,970 463 581 774 1,190 3,008 Less: Net income attributable to noncontrolling interests 8 2 8 6 23 5 4 6 11 27 8 2 8 11 29 Net income (loss) attributable to Baker Hughes Company $ 72 $ (839) $ (17) $ 182 $ (601) $ 576 $ 410 $ 518 $ 439 $ 1,943 $ 455 $ 579 $ 766 $ 1,179 $ 2,979 Table 2. Consolidated Statements of Income (Loss) - by Quarter Recasted View ($ in millions) Note: certain columns and rows may not add up due to the use of rounded numbers. (1) Cost of sales excludes "Research and development costs," which are now separately stated on the Consolidated statements of income (loss) (2) The caption previously named "Restructuring, Impairment & Other" has been renamed to "Restructuring" with all non-restructuring costs reclassified to "Other (income) expense, net" (3) Costs previously reported in "Other non-operating (income) loss" will now be classified in "Other (income) expense, net"